Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
FHTX on Nasdaq
Shares outstanding
76,378,254
Price per share
$5.40
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
41,875,144
Total reported value
$226,126,895
% of total 13F portfolios
0%
Share change
+974,907
Value change
+$5,631,628
Number of holders
93
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flagship Ventures Fund V, L.P. 27% $112,194,766 20,774,885 Noubar Afeyan 09 Jan 2026
FMR LLC 10% $24,977,866 5,689,719 FMR LLC 31 Dec 2024

As of 31 Dec 2025, 93 institutional investors reported holding 41,875,144 shares of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX). This represents 55% of the company’s total 76,378,254 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) together control 53% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Flagship Pioneering, LLC 17% 12,674,120 0% 21% $68,440,247
FMR LLC 7.1% 5,396,814 -1.4% 0% $29,142,795
BVF INC/IL 6.9% 5,302,000 0% 0.96% $28,630,800
DEERFIELD MANAGEMENT COMPANY, L.P. 4.8% 3,649,211 +12% 0.25% $19,705,739
RAYMOND JAMES FINANCIAL INC 3.3% 2,505,821 +1.8% 0% $13,531,433
BlackRock, Inc. 3.1% 2,349,870 +4% 0% $12,689,297
VANGUARD GROUP INC 2.5% 1,928,992 +1.6% 0% $10,416,557
Euclidean Capital LLC 2.1% 1,573,761 0% 2.3% $8,498,309
GEODE CAPITAL MANAGEMENT, LLC 1% 795,040 -1.7% 0% $4,294,265
Siren, L.L.C. 0.94% 720,720 0% 0.12% $3,891,888
STATE STREET CORP 0.81% 618,666 -2.9% 0% $3,340,796
AMERIPRISE FINANCIAL INC 0.8% 607,670 0% $3,281,419
RENAISSANCE TECHNOLOGIES LLC 0.39% 297,736 +152% 0% $1,607,774
Birchview Capital, LP 0.37% 281,730 0% 0.89% $1,521,342
JACOBS LEVY EQUITY MANAGEMENT, INC 0.35% 269,186 +46% 0.01% $1,453,604
NORTHERN TRUST CORP 0.34% 262,430 -7.7% 0% $1,417,122
MILLENNIUM MANAGEMENT LLC 0.27% 208,565 +17% 0% $1,126,251
CITADEL ADVISORS LLC 0.24% 182,276 +1416% 0% $984,291
Squarepoint Ops LLC 0.19% 141,580 +287% 0% $764,532
JANE STREET GROUP, LLC 0.17% 132,501 +100% 0% $715,505
DAFNA Capital Management LLC 0.17% 126,859 0% 0.16% $685,039
Sio Capital Management, LLC 0.16% 122,889 0% 0.11% $663,601
MORGAN STANLEY 0.16% 121,727 +91% 0% $657,327
GOLDMAN SACHS GROUP INC 0.16% 118,701 +64% 0% $640,985
SCS Capital Management LLC 0.14% 106,980 0% 0.01% $577,692

Institutional Holders of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 41,875,144 $226,126,895 +$5,631,628 $5.40 93
2025 Q3 40,899,067 $199,997,332 -$252,615 $4.89 86
2025 Q2 40,966,679 $192,544,370 +$2,995,463 $4.70 79
2025 Q1 40,422,738 $147,539,082 +$554,807 $3.65 89
2024 Q4 40,250,865 $189,972,345 +$1,515,315 $4.72 86
2024 Q3 39,996,016 $372,365,052 +$3,205,361 $9.31 78
2024 Q2 39,443,565 $226,852,214 +$74,393,685 $5.75 71
2024 Q1 26,459,793 $177,447,258 +$1,618,684 $6.71 67
2023 Q4 26,194,106 $168,954,975 -$3,389,727 $6.45 59
2023 Q3 26,924,936 $134,628,591 +$778,966 $5.00 61
2023 Q2 26,763,756 $188,422,208 +$3,982,788 $7.04 59
2023 Q1 26,253,067 $162,763,500 +$937,198 $6.20 61
2022 Q4 26,093,883 $166,474,381 -$1,442,468 $6.38 63
2022 Q3 26,307,921 $225,720,907 +$12,954 $8.58 60
2022 Q2 26,276,584 $357,367,427 +$18,367,020 $13.60 55
2022 Q1 24,903,791 $379,088,288 +$4,677,182 $15.23 57
2021 Q4 24,151,188 $552,334,813 +$1,462,679 $22.87 58
2021 Q3 11,606,587 $161,634,440 +$5,200,204 $13.93 44
2021 Q2 11,234,597 $119,870,494 +$2,946,090 $10.67 36
2021 Q1 10,646,057 $139,604,845 -$678,194 $13.18 43
2020 Q4 10,612,558 $212,930,838 +$187,364,837 $20.27 45